MDxHealth SA

MDXH Nasdaq CIK: 0001872529

Company Information

Industry Services-Medical Laboratories
SIC Code 8071
Entity Type other
SEC Category Non-accelerated filerEmerging growth company
State of Incorporation Belgium
Business Address CAP BUSINESS CENTER, HERSTAL, C9, 00000
Mailing Address CAP BUSINESS CENTER, HERSTAL, C9, 00000
Phone 949-271-9221
EIN 000000000

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
20-F Foreign company annual report April 3, 2026 View on SEC
3 Initial insider ownership report March 18, 2026 View on SEC
3 Initial insider ownership report March 18, 2026 View on SEC
6-K Foreign company current report February 26, 2026 View on SEC
6-K Foreign company current report February 11, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 16, 2026 View on SEC
6-K Foreign company current report January 12, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment November 14, 2025 View on SEC
6-K Foreign company current report November 12, 2025 View on SEC
6-K Foreign company current report September 16, 2025 View on SEC

Annual Reports

20-F April 3, 2026
  • Advanced diagnostic portfolio including Confirm mdx, GPS mdx, and Exo mdx.
  • Exo mdx test demonstrates 91% accuracy in helping patients avoid unnecessary biopsies.
View Analysis

Related Companies

Companies in the same industry (SIC: 8071)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.